News
Analyst Scoreboard: 6 Ratings For Xencor
16 Apr 24
Analyst Ratings
BTIG Maintains Buy on Xencor, Lowers Price Target to $38
16 Apr 24
News, Price Target, Analyst Ratings
Piper Sandler Downgrades Xencor to Neutral, Lowers Price Target to $24
28 Feb 24
News, Downgrades, Price Target, Analyst Ratings
Unveiling 4 Analyst Insights On Xencor
28 Feb 24
Analyst Ratings
RBC Capital Reiterates Outperform on Xencor, Maintains $32 Price Target
28 Feb 24
News, Price Target, Reiteration, Analyst Ratings
BMO Capital Maintains Outperform on Xencor, Lowers Price Target to $34
28 Feb 24
News, Price Target, Analyst Ratings
Wedbush Maintains Outperform on Xencor, Lowers Price Target to $34
28 Feb 24
News, Price Target, Analyst Ratings
Recap: Xencor Q4 Earnings
27 Feb 24
Earnings
Xencor Q4 2023 GAAP EPS $(0.31) Misses $(0.09) Estimate, Sales $44.69M Miss $73.84M Estimate
27 Feb 24
Earnings, Earnings Misses, News
Earnings Scheduled For February 27, 2024
27 Feb 24
Earnings
Earnings Preview: Xencor
26 Feb 24
Earnings
Navigating 4 Analyst Ratings For Xencor
22 Jan 24
Analyst Ratings
Mizuho Maintains Buy on Xencor, Lowers Price Target to $50
22 Jan 24
News, Price Target, Analyst Ratings
Press releases
Xencor Appoints Bart Cornelissen as Chief Financial Officer
9 Apr 24
Press Releases
Xencor to Present at Upcoming Investor Conferences
28 Feb 24
Press Releases
Xencor Reports Fourth Quarter and Full Year 2023 Financial Results
27 Feb 24
Press Releases
Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update
20 Feb 24
Press Releases